MediaAlpha, Inc. (MAX) SEC Filings & Earnings Calls
EquiReason read 21 MediaAlpha, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-09 — MediaAlpha purchases PLX's interest in Tax Receivables Agreement for $12M cash, a 47% discount to estimated value, reducing future liability by ~$22.7M..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 729.0M
- P/E TTM
- 7.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
9 Sep 20268-K · 1.01MediaAlpha purchases PLX's interest in Tax Receivables Agreement for $12M cash, a 47% discount to estimated value, reducing future liability by ~$22.7M.open
Figures in the filing · each found in the filing text
| TRA liability purchased amount · corporate · September 9, 202 | $12M | |
| Discount on TRA purchase · corporate · September 9, 202 | $11M | |
| Estimated total TRA liability · corporate · June 30, 2026 | $55M | |
| Estimated remaining TRA liability · corporate · September 30, 20 | $32M |
Risks flagged
Pro rata distribution from QLH to members may raise governance concerns.
“QLH (a partnership subsidiary of the Company) made a pro rata distribution to its members, which included certain directors and executive officers of the Company.” · word for word
3 Sep 20268-K · 5.02, 7.01MediaAlpha expects Q3 2026 Revenue, Contribution, and Adjusted EBITDA at or above top end of prior guidance; also announced CFO transition with Tigran Sinanyan succeeding Pat Thompson.open
Guidance
Q3 2026 Revenue, Contribution, Adjusted EBITDA at or above top end of prior guidance
MediaAlpha raised Q3 2026 guidance to at or above top end; CFO transition with experienced insider; strong demand recovery in P&C insurance
Risks flagged
CFO transition could cause temporary operational disruption
“Pat Thompson will step down as CFO, effective October 1, 2026; Tigran Sinanyan to succeed”
26 Aug 2026SC 13D/AEugene Nonko and O.N.E. Holdings, LLC filed an amended Schedule 13D disclosing a 9.8% beneficial ownership stake in MediaAlpha, Inc., with no stated activist intent.open
Risks flagged
Insider selling pressure
“Between February 27, 2025 and August 26, 2026, Mr. Nonko sold an aggregate of 1,265,428 shares of Class A Common Stock in the following open market transactions” · word for word
26 Aug 2026SC 13D/AEugene Nonko and O.N.E. Holdings, LLC filed an amended Schedule 13D disclosing a 9.8% beneficial ownership stake in MediaAlpha, Inc., with no stated activist intent.open
Risks flagged
Insider selling pressure
“Between February 27, 2025 and August 26, 2026, Mr. Nonko sold an aggregate of 1,265,428 shares of Class A Common Stock in the following open market transactions” · word for word
29 Jul 20268-K · 2.02Revenue $317M (+26% y/y); Gross margin 14.3; Contribution Margin 14.9; Guidance: Q3 revenue midpoint $342.5M (+12% YoY), contribution midpoint $53M (+16% YoY), Adj. EBITDA midpoint $33.5M (+15% YoY)earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $317M | +26% y/y |
| Gross margin · Q2-2026 | 14.3% | |
| Contribution Margin · Q2-2026 | 14.9% | |
| Net income · Q2-2026 | $42M | |
| Adjusted EBITDA · Q2-2026 | $29M | +20% y/y |
Guidance
Q3 revenue midpoint $342.5M (+12% YoY), contribution midpoint $53M (+16% YoY), Adj. EBITDA midpoint $33.5M (+15% YoY)
Record Q2 results and raised Q3 guidance driven by P&C insurance vertical strength; slight margin compression but strong cash flow and buybacks.
Risks flagged
Gross margin compression due to mix shift or cost pressures.
“Gross margin declined from 15.0% to 14.3% YoY”
Health vertical remains negligible at ~1% of revenue, limiting diversification.
“Health insurance vertical to account for approximately 1% of revenue” · word for word
29 Jul 202610-QMediaAlpha reported strong Q2 2026 results with revenue up 25.9% YoY, driven by P&C insurance demand, and net income of $41.8M vs a loss last year.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $317M | +26% y/y |
| Net income (loss) · Q2-2026 | $42M | |
| Adjusted EBITDA · Q2-2026 | $29M | +20% y/y |
| Contribution · Q2-2026 | $47M | +18% y/y |
| Contribution Margin · Q2-2026 | 14.9% | |
| P&C Insurance Revenue · Property & Casualty insurance · Q2-2026 | $309M | +36% y/y |
| Health Insurance Revenue · Health insurance · Q2-2026 | $3M | -85% y/y |
| Life Insurance Revenue · Life insurance · Q2-2026 | $5M | -2% y/y |
| Operating Cash Flow · H1-2026 | $41M | -17% y/y |
Guidance
Full year 2026 under-65 health revenue guided to $5.0M-$6.0M
Management provided guidance for under-65 health revenue of $5-6M for full year 2026, indicating continued scaling back, while P&C demand remains strong.
Risks flagged
Health Insurance Vertical Decline
“The decrease in health insurance revenue for the three months ended June 30, 2026, compared with the three months ended June 30, 2025, was driven primarily by our actions to scale back the under-65 Health sub-vertical. Additionally, revenue from the Medicare sub-vertical declined due to industry-wide headwinds resulting from increases in the Medical Loss Rat” · word for word
FTC Matter Legal Exposure
“Legal expenses for the three and six months ended June 30, 2025, consist of increases of $33.0 million and $38.0 million, respectively, to the loss reserve established in connection with the FTC Matter and legal fees and costs incurred in connection with such matter.” · word for word
29 Jun 20268-K · 1.01MediaAlpha purchased Insignia's TRA interest for $31M cash, a 55% discount to estimated value, reducing total TRA liability from $123.4M to ~$55M. This is a liability management transaction, not a standard M&A or contract event.open
Risks flagged
Remaining TRA liability still $55M, and transaction funded partly by borrowings under revolving credit facility.
“Company funded such payment from its subsidiaries' cash on hand and borrowings under its secured revolving credit facility.”
18 May 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
No new risks.
29 Apr 20268-K · 2.02Revenue $310M (+17% y/y); Gross margin 15.1; Contribution Margin 15.7; Guidance: Q2 revenue midpoint $300M (+19% YoY), contribution midpoint $47M (+18% YoY), Adj. EBITDA midpoint $29.25M (+19% YoY)earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $310M | +17% y/y |
| Gross margin · Q1-2026 | 15.1% | |
| Contribution Margin · Q1-2026 | 15.7% | |
| Net income · Q1-2026 | $14M | |
| Adjusted EBITDA · Q1-2026 | $31M | +7% y/y |
Guidance
Q2 revenue midpoint $300M (+19% YoY), contribution midpoint $47M (+18% YoY), Adj. EBITDA midpoint $29.25M (+19% YoY)
Record Q1 results and raised Q2 guidance driven by P&C insurance vertical strength; slight margin compression but strong cash flow and buybacks.
Risks flagged
Gross margin compression due to mix shift or cost pressures.
“Gross margin declined from 15.8% to 15.1% YoY”
Health vertical remains negligible at ~1% of revenue, limiting diversification.
“Health insurance vertical to account for approximately 1% of revenue” · word for word
29 Apr 202610-QMediaAlpha reported strong Q1 2026 results with revenue up 17.3% YoY, driven by P&C insurance demand, and net income of $14.0M vs a loss last year.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $310M | +17% y/y |
| Net income (loss) · Q1-2026 | $14M | |
| Adjusted EBITDA · Q1-2026 | $31M | +7% y/y |
| Contribution · Q1-2026 | $49M | +11% y/y |
| Contribution Margin · Q1-2026 | 15.7% | |
| P&C Insurance Revenue · Property & Casualty insurance · Q1-2026 | $293M | +31% y/y |
| Health Insurance Revenue · Health insurance · Q1-2026 | $11M | -67% y/y |
| Life Insurance Revenue · Life insurance · Q1-2026 | $6M | +5% y/y |
Guidance
Full year 2026 under-65 health revenue guided to $4.5M-$5.5M
Management provided guidance for under-65 health revenue of $4.5-5.5M for full year 2026, indicating continued scaling back, while P&C demand remains strong.
Risks flagged
Health Insurance Vertical Decline
“The decrease in health insurance revenue for the three months ended March 31, 2026, compared with the three months ended March 31, 2025, was due primarily to our actions to scale back the under-65 Health sub-vertical and address concerns raised by the FTC. Additionally, revenue from the Medicare sub-vertical declined due to industry-wide headwinds resulting ” · word for word
FTC Matter Legal Exposure
“Legal expenses for the three months ended March 31, 2025, consist of an increase of $5.0 million to the loss reserve established in connection with the FTC Matter and legal fees and costs incurred in connection with such matter.” · word for word
30 Mar 20268-K · 1.01MediaAlpha subsidiary entered a $150M term loan and $60M revolving credit facility, refinancing existing debt and providing general corporate liquidity.open
Risks flagged
Increased debt load with $150M term loan, though extended maturity reduces near-term refinancing risk.
“new five-year senior secured term loan facility in an aggregate principal amount of $150 million” · word for word
23 Mar 2026DEF 14ATransaction Value from P&C insurance vertical $1.90B (+65% y/y); Revenue $1.00B; Net income $27M (+21% y/y)open
Figures in the filing · each found in the filing text
| Transaction Value from P&C insurance vertical · P&C insurance · FY2025 | $1.90B | +65% y/y |
| Revenue · FY2025 | $1.00B | |
| Net income · FY2025 | $27M | +21% y/y |
| Adjusted EBITDA · FY2025 | $114M | +18% y/y |
| Transaction Value (target for bonus) · FY2025 | $1.89B | |
| Adjusted EBITDA (target for bonus) · FY2025 | $122M | |
| CEO target total compensation at-risk · FY2025 | $91.00 | |
| Average other NEO target total compensation at-risk · FY2025 | $84.00 | |
| Shares repurchased from Insignia · 2025-09-03 | $3M | |
| Repurchase price per share · 2025-09-03 | $10.17 |
23 Feb 202610-KTransaction Value $2.20B (+44% y/y); Revenue $1.10B (+29% y/y); Adjusted EBITDA $114M (+18% y/y)open
Figures in the filing · each found in the filing text
| Transaction Value · FY2025 | $2.20B | +45% y/y |
| Revenue · FY2025 | $1.10B | +29% y/y |
| Adjusted EBITDA · FY2025 | $114M | +18% y/y |
| Net Income · FY2025 | $27M | +21% y/y |
| Consumer Referrals · FY2025 | 141,000,000 | |
| Number of Employees · FY2025 | 147 | +6% y/y |
| Capital Expenditures · FY2025 | $300000.00 | -57% y/y |
Risks flagged
FTC consent order impact on under-65 health business
“The FTC Matter has had, and may continue to have, a material adverse effect on our under-65 health business.” · word for word
Regulatory changes in Medicare marketing
“Medicare providers and their brokers and marketing partners are subject to the regulations governing the marketing and sale of Medicare Advantage and Medicare Supplement plans, which are administered by the Centers for Medicare and Medicaid Services ("CMS"), have materially changed the rules regarding how such policies are marketed, and may materially restri” · word for word
Customer concentration risk
“No specific customer concentration data is provided, but the business model relies on a limited number of large insurance carriers.”
23 Feb 20268-K · 2.02, 8.01Revenue $291M (-3% y/y); Transaction Value $613M (+23% y/y); Transaction Value from Property & Casualty $552M (+38% y/y); Guidance: Q1 2026 TV midpoint $582.5M, +23% YoY; P&C TV +35% YoYearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q4-2025 | $291M | -3% y/y |
| Transaction Value · Q4-2025 | $613M | +23% y/y |
| Transaction Value from Property & Casualty · Property & Casualty · Q4-2025 | $552M | +38% y/y |
| Transaction Value from Health · Health · Q4-2025 | $54M | -40% y/y |
| Gross margin · Q4-2025 | 15.4% | |
| Contribution Margin · Q4-2025 | 16.1% | |
| Net income · Q4-2025 | $34M | |
| Adjusted EBITDA · Q4-2025 | $31M | |
| Revenue · FY2025 | $1.10B | +29% y/y |
| Transaction Value · FY2025 | $2.20B | +45% y/y |
Guidance
Q1 2026 TV midpoint $582.5M, +23% YoY; P&C TV +35% YoY
P&C momentum strong; health headwind persists. Overall TV growth guided +23% YoY.
Risks flagged
Health vertical continues to decline sharply, down 40% YoY in Q4 and expected to decline ~50% in Q1 2026.
“Transaction Value from Health of $54 million, a decrease of 40% year over year; Q1 2026 guidance: Health TV decline ~50% YoY” · word for word
29 Oct 202510-QMediaAlpha reported Q3 2025 revenue of $306.5M, up 18.3% YoY, with strong P&C growth offset by Health decline and FTC settlement.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $307M | +18% y/y |
| Transaction Value · Q3-2025 | $589M | +30% y/y |
| Contribution · Q3-2025 | $46M | +10% y/y |
| Contribution Margin · Q3-2025 | 14.9% | |
| Net Income · Q3-2025 | $18M | +48% y/y |
| Adjusted EBITDA · Q3-2025 | $29M | +11% y/y |
| P&C Insurance Revenue · Property & Casualty insurance · Q3-2025 | $288M | +31% y/y |
| Health Insurance Revenue · Health insurance · Q3-2025 | $13M | -61% y/y |
| Life Insurance Revenue · Life insurance · Q3-2025 | $6M | +7% y/y |
| Cash and Cash Equivalents · 2025-09-30 | $72M |
Guidance
Full year 2025 under-65 health revenue expected to be $69-72M, down from prior levels
Management expects continued strong P&C momentum but Health revenue will be reduced by $69-72M for full year 2025 due to FTC actions.
Risks flagged
FTC Consent Order Compliance and Monetary Relief
“Under the terms of the Consent Order, which includes no admission or denial of wrongdoing or to the FTC’s allegations, the Company has agreed to pay $45.0 million as monetary relief.” · word for word
Health Insurance Vertical Decline
“The decrease in health insurance revenue for the three months ended September 30, 2025, compared with the three months ended September 30, 2024, was due primarily to our actions to scale back the under-65 Health sub-vertical and address concerns raised by the FTC.” · word for word
Debt Maturity and Refinancing Risk
“The remaining lenders, representing $13.3 million and $0.4 million of the principal amount outstanding under the 2021 Term Loan Facility and the 2021 Revolving Credit Facility, respectively, as of that date, will mature on July 29, 2026.” · word for word
29 Oct 20258-K · 2.02, 8.01Revenue $306M (+18% y/y); Transaction Value $589M (+30% y/y); Transaction Value from Property & Casualty $548M (+41% y/y); Guidance: Q4 2025 TV midpoint $632.5M, +27% YoY; P&C TV +45% YoYearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $307M | +18% y/y |
| Transaction Value · Q3-2025 | $589M | +30% y/y |
| Transaction Value from Property & Casualty · Property & Casualty · Q3-2025 | $548M | +41% y/y |
| Transaction Value from Health · Health · Q3-2025 | $33M | -40% y/y |
| Gross margin · Q3-2025 | 14.2% | |
| Contribution Margin · Q3-2025 | 14.9% | |
| Net income · Q3-2025 | $18M | |
| Adjusted EBITDA · Q3-2025 | $29M |
Guidance
Q4 2025 TV midpoint $632.5M, +27% YoY; P&C TV +45% YoY
P&C momentum strong; health headwind persists. Overall TV growth guided +27% YoY.
Risks flagged
Health vertical continues to decline sharply, down 40% YoY in Q3 and expected to decline ~45% in Q4.
“Transaction Value from Health down 40% year over year to $33 million; Q4 guidance: Health TV decline ~45% YoY” · word for word
MediaAlpha, Inc. — questions
- What did MediaAlpha, Inc. file recently?
- 21 SEC filings in the last 12 months. Latest: 8-K on 2026-09-09 — MediaAlpha purchases PLX's interest in Tax Receivables Agreement for $12M cash, a 47% discount to estimated value, reducing future liability by ~$22.7M.
Every figure on this page comes from MediaAlpha, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.